Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 19Triple Negative Breast Neoplasms 2Cardiotoxicity 2Ovarian Neoplasms 1Obesity 1Inflammation 1Hot Flashes 1Highly Endocrine Responsive Operable Breast Cancer 1Genetic Diseases, Inborn 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Advanced Breast Cancer 1

Interventions

Acupuncture Therapy 5Gabapentin 4Venlafaxine Hydrochloride 3Estrogens, Conjugated (USP) 3liposomal amphotericin B 2Tamoxifen 2Magnesium Oxide 2Hypnosis 2Control Groups 2Citalopram 2oxybutynin 1black cohosh root extract 1bazedoxifene 1Zolpidem 1Testosterone 1Tablets 1Soybean Proteins 1Solifenacin Succinate 1Sodium Chloride 1Sertraline 1Progesterone 1Pregabalin 1N,N'-(1,4-phenylenebis(methylene))dipyrimidin-2-amine 1Mindfulness 1Mind-Body Therapies 1Megestrol Acetate 1Medroxyprogesterone 1Linseed Oil 1Isoflavones 1Hypericum extract LI 160 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hot Flashes × Tablets × Breast × Clear all
NCT06774885 2025-01-14

ROLE OF FOLIC ACID IN THE MANAGEMENT OF ADJUVANT ENDOCRINE THERAPY-INDUCED HOT FLASHES IN BREAST CANCER PATIENTS

Future University in Egypt

Phase 3 Not yet recruiting
120 enrolled
Breast

Breast Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡